{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04524",
    "Peptide Name": "YZ107 (Synthetic AMPs, teixobactin-derived, Leu-rich, XXA, UCLL1c)",
    "Source": "designed, bacteria-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FLSKILSTLRILF",
    "Sequence Length": 13,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA",
      "Hemolytic"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -0.43,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "62%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) toYZ105L: 31%, I=F=S: 15%.Activity: active against S. aureus USA300 LAC (MIC 2 uM),\tS. epidermidis 1457 (MIC 2 uM), E. coli E423-17 (MIC 8 uM), \tA. aumannii B28-16 (MIC 4-8 uM),\tP. aeruginosa E411-17 (MIC 8-16 uM), and\tK-pneumoniae E406-17 (MIC > 16 uM).In vitro toxicity: human RBC HC50 25 uM, hemolytic.",
    "Author": "Wu Q, Mishra B, Wang G. 2022",
    "Reference": "Pept Sci (Hoboken). 2022 Sep;114(5):e24269. doi: 10.1002/pep2.24269.PubMed",
    "Title": "Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism."
  },
  "3D Structure": []
}